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ABSTRACT 
MILTON, A.L. and Everitt, B.J. The persistence of (maladaptive) memory: addiction, drug 
memories and anti-relapse treatments. NEUROSCI BIOBEHAV REV X(X): XXX-XXX, 2012. 
Addiction is a chronic, relapsing disorder, characterised by the long-term propensity of 
addicted individuals to relapse. A major factor that obstructs the attainment of abstinence is 
the persistence of maladaptive drug-associated memories, which can maintain drug-seeking 
and taking behaviour and promote unconscious relapse of these habits. Thus, addiction can 
be conceptualised as a disorder of aberrant learning: of the formation of strong instrumental 
memories linking actions to drug-seeking and taking outcomes that ultimately are expressed 
as persistent stimulus-response habits; of previously neutral environmental stimuli that 
become associated with drug highs (and/or withdrawal states) through pavlovian 
conditioning, and of the subsequent interactions between pavlovian and instrumental 
memories to influence relapse behaviour. Understanding the psychological, neurobiological 
and molecular basis of these drug memories may produce new methods of pro-abstinence, 
anti-relapse treatments for addiction.  
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1. INTRODUCTION 
Addiction, from the Latin addicere (‘to sentence’), is a chronic, relapsing disorder that is 
problematic for both the individual and society. Drug addiction incurs high social and 
economic costs, placing major demands on policing and medical resources. In the UK, the 
cost of harm from Class A drug use was estimated at £15.4 billion in 2003-04 (Gordon et al., 
2006). This considerable expense would be significantly reduced by implementing successful 
treatment programmes; for example, it has been estimated that if all heroin addicts 
complied with methadone treatment, the UK government would save £3-4 billion over 5 
years (Cave and Godfrey, 2006). Addiction is synonymous with the term ‘substance 
dependence’ in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IVR) and the 
International Statistical Classification of Diseases and Related Health Problems (ICD10; Table 
1). Both recognise drug addiction when an individual shows loss of control over drug taking 
behaviour, persistence of drug-taking behaviour despite negative consequences, and high 
motivation to take the drug at the expense of other activities.  
Addiction can be analysed and conceptualised at several levels, from the 
psychological to the molecular biological. This article reviews addiction with a focus on how 
it can be conceptualised as a disorder of maladaptive memory, considering the psychological 
and neural basis of addictive drug-associated memories (§2 and §3) before discussing how 
pharmacological manipulation of these memories could be used to treat addiction (§4). A 
major problematic aspect of addiction, both clinically and for the individual, is its chronic and 
relapsing nature, with the propensity to relapse persisting long after the more obvious signs 
of acute withdrawal have abated (Gawin and Kleber, 1992). Treatments based on the 
disruption of drug memory reconsolidation, or facilitated extinction of drug memories, 
unlike currently available therapies, would target the memories that underlie the disorder to 
diminish the propensity to relapse long into abstinence (§5).  
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2. PSYCHOLOGICAL ASSOCIATIONS UNDERLYING ADDICTION 
2.1. Drug addiction can be viewed as the aberrant engagement of normal learning 
processes, leading to the formation of persistent maladaptive memories 
The long-term propensity of an addict to relapse suggests that it is not solely acute drug 
withdrawal effects, such as those found in abstinent opiate addicts (Wikler, 1948) that 
maintain drug use, but rather that persistent changes in brain function occur, ultimately 
leading to a prolonged risk of relapse following initial detoxification. One theory of addiction 
(Everitt et al., 2001; Everitt and Robbins, 2005) hypothesises that the long-term propensity 
to relapse reflects the formation of drug-associated memories that can not only maintain 
drug-seeking and drug-taking behaviour while the addict is abusing the drug, but also can 
precipitate drug-seeking behaviour following a period of abstinence. This theory emphasises 
that learning processes can account for the long-term risk of relapse in addicts, since these 
maladaptive memories can be remarkably persistent (Di Ciano and Everitt, 2004a).  
 This conceptualisation of addiction as the aberrant engagement of normal learning 
processes makes psychological and neurobiological studies of learning and motivation 
relevant to addiction research. Everitt, Dickinson & Robbins (2001) argued that the aberrant 
engagement of pavlovian and instrumental learning mechanisms, due perhaps to the ability 
of drugs of abuse to increase dopamine release in parts of the limbic cortico-ventral striatal 
system, leads to enhanced learning about the actions and environmental, drug-associated 
cues or conditioned stimuli (CSs) that predict opportunities for drug self-administration. 
Consequently, these CSs acquire an increasing role in controlling drug seeking behaviour. 
With repeated drug-taking, the dorsal striatum becomes progressively more engaged by the 
CSs that have been previously paired with drug self-administration, mediated by the 
dopaminergic circuitry that links the limbic cortical areas activated by these CSs, including 
the amygdala, with motor control areas (Figure 1). Therefore, as the state of addiction 
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develops, the previously drug-paired CSs come to elicit drug-seeking and taking behaviour, 
independently of GOAL-DIRECTED
1
 action; drug-seeking and taking become controlled by 
stimulus-response mechanisms that are habitual and automatic, via CS-induced activation of 
drug-seeking motor programmes in the dorsal striatum (Belin and Everitt, 2008; Belin et al., 
2009). Drug seeking ultimately becomes compulsive, being inflexible, persistent and 
insensitive to devaluation or PUNISHMENT (Belin and Everitt, 2008; Everitt and Robbins, 2005), 
reflecting one of the key characteristics of drug addiction, as defined in DSM-IVR and ICD-10 
(Table 1). This progression from goal-directed, ‘action-outcome’ instrumental behaviour to 
compulsive and HABITUAL ‘STIMULUS-RESPONSE’ instrumental behaviour, driven by repetition in 
the presence of pavlovian conditioned stimuli, may reflect a more rapid transition of the 
normal, adaptive, learning processes that occur with overtraining in working for natural 
reinforcers. Thus addiction can be viewed as the aberrant engagement of normally adaptive 
learning processes, which through the content of the underlying associations becomes 
maladaptive. 
2.2. Specific psychological associations underlying drug addiction 
The associations that form when an individual seeks and takes drugs of abuse are both 
pavlovian (non-contingent on behaviour) and instrumental (behaviourally contingent) in 
their nature; whether these are between stimuli in the environment that are present during 
drug-taking behaviour, or are predictive of drug availability (‘stimulus-outcome’, or S-O 
associations), the responses that are necessary to obtain and take the drug (‘action-
outcome’, or A-O, associations) or, with extensive training, associations between the drug-
conditioned stimuli and the actions of drug-seeking and –taking (‘stimulus-response’, or S-R, 
associations). We will consider these associations and their impact on drug-seeking and 
relapse behaviour, in turn. 
                                                             
1
 See Table 2 for definitions of psychological terms. 
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2.2.1. Pavlovian associations 
A pavlovian association is one that develops between a neutral stimulus present within the 
environment (the ‘CONDITIONED STIMULUS’, or CS) and a particular consequence (the 
‘UNCONDITIONED STIMULUS’, or US), whether this is an outcome (‘S-O’ associations) or another 
stimulus ('S-S' associations; Pavlov, 1927). Importantly, pavlovian associations are 
independent of the individual’s behaviour; the association forms because of the contingency 
between the CS and the US. However, because PAVLOVIAN CONDITIONING confers incentive 
motivational value on the previously motivationally neutral CS, the CS can come to support 
behaviour in its own right, for example by: (i) eliciting a behaviour known as pavlovian 
CONDITIONED APPROACH (Brown and Jenkins, 1968) as measured in the ‘AUTOSHAPING’ 
procedure, where the individual approaches stimuli (‘sign-tracking’) or locations (‘goal-
tracking’) that have previously been paired with REINFORCEMENT; (ii) acquiring reinforcing 
properties through its association with the outcome, a process known as CONDITIONED 
REINFORCEMENT (Hyde, 1976; Mackintosh, 1974) and; (iii) influencing the performance of an 
ongoing instrumental response that has been associated with the same (or sometimes a 
different) REWARD as the stimulus, a process known as PAVLOVIAN-INSTRUMENTAL TRANSFER 
(Bindra, 1968; Estes, 1943; Lovibond, 1983). We have reviewed the importance of these 
three pavlovian processes in addictive behaviour previously (Milton and Everitt, 2010) and 
so will not discuss them further here. However, in addition to mediating these positive 
incentive motivational effects, CSs associated with drug can also become associated with the 
negative incentive motivational effect of CONDITIONED WITHDRAWAL, in addition to conditioned 
tolerance and conditioned sensitisation. Some influential theories of addiction (Koob and Le 
Moal, 1997, 2008; Wikler, 1948) particularly emphasise the importance of the conditioned 
withdrawal association on drug-seeking and drug-taking behaviour, and so this warrants 
further consideration. 
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2.2.1.1. Conditioned withdrawal 
Several theories of addiction emphasise the importance of withdrawal in producing negative 
affective states that elicit craving and maintain drug-seeking behaviour (Koob and Le Moal, 
1997; Wikler, 1948) and, as with the positive reinforcing aspects of addictive drug-taking, the 
negative reinforcing aspects of withdrawal can undergo pavlovian conditioning. The original, 
still influential, theory of Wikler (1948) proposed that repeated pairings of stimuli present 
during withdrawal from opiates could lead to the conditioned elicitation of withdrawal 
symptoms; thus, the presentation of previously withdrawal-associated CSs could produce 
withdrawal responses as a CONDITIONED RESPONSE. In this way, environmental CSs predictive of 
withdrawal could support the development of withdrawal-like symptoms (including negative 
affect), and promote further drug use to alleviate these symptoms, a form of NEGATIVE 
INSTRUMENTAL REINFORCEMENT (see §2.2.2.2). There is debate over the relative importance of 
conditioned withdrawal on relapse behaviour (Lyvers, 1998; McAuliffe, 1982) because 
physiological withdrawal is relatively short-lived compared to lifetime relapse risk, and 
because it is difficult to demonstrate experimentally that conditioned withdrawal increases 
drug-seeking behaviour, due to concurrent withdrawal-induced response suppression 
(Goldberg and Schuster, 1967; Miller et al., 1979; Wikler and Pescor, 1967). However, 
several studies support the existence of conditioned withdrawal effects (Childress et al., 
1984; O'Brien et al., 1976; Schnur, 1992; Wikler and Pescor, 1967) and, coupled with 
negative reinforcement (§2.2.2.2) conditioned withdrawal could act to influence drug-
seeking and drug-taking behaviour. 
2.2.1.2. Conditioned tolerance and sensitisation 
Tolerance is the progressive reduction in the effects of a specific dose of drug following 
repeated administration, and it can be manifest behaviourally as an increase in the amount 
of drug taken in order to achieve the same subjective and behavioural effect. Tolerance to 
drug effects is also one of the seven diagnostic criteria for substance abuse in the DSM-IVR 
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definition of addiction (Table 1). It can be contrasted to drug sensitisation, in which the 
response to the drug of abuse increases with repeated administration.  
The psychological mechanisms underlying tolerance have been the subject of debate 
within the addiction and pain literature, particularly concerning whether tolerance is learned 
or simply a neuroadaptation to the acute but frequently occurring neurochemical effects of 
the abused drug. ‘Opponent-process’ theories (Solomon and Corbit, 1974) argue that drug 
withdrawal and drug tolerance are related neuroadaptations, because while withdrawal 
symptoms reflect the sudden change in activity of an adapted homeostatic system following 
the rapid removal of the drug from that system, tolerance reflects the reduced response of 
the same system in the presence of the drug (Siegel, 1977). Evidence supporting these 
theories has come largely from studies using morphine as the drug of abuse (Mucha et al., 
1979) although ‘opponent-process’ theories of addiction have also been convincingly argued 
to apply to psychostimulants, although in a more generalised, hedonic form in which 
negative affective (hedonic) states, rather than physical signs, are the motivating force (Koob 
and Le Moal, 1997). 
An alternative view is that tolerance reflects learning, whether associative 
(pavlovian) or non-associative (habituation). Habituation is a form of non-associative 
learning in which the response to a stimulus reduces following repeated, unreinforced 
presentations of that stimulus. Baker & Tiffany (1985) argue that tolerance can be viewed as 
habituation, generated through expectancy of a drug’s effect and so accounting for the 
contextual specificity of tolerance. Alternatively, tolerance may be a form of ‘self-generated 
priming’, in which previous experience with the drug primes an expectancy of the drug’s 
effect, which Baker & Tiffany (1985) argue accounts for tolerance where there is no obvious 
context or CS associated with the drug. This could account for the development of apparent 
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‘drug opposite’ effects in contexts in which the drug is expected but not administered 
(Stewart et al., 1984).  
Alternatively, tolerance may be conditioned (Siegel, 1975) rather than non-
associative. There is extensive evidence that tolerance can be influenced by CSs and 
contexts, particularly when morphine is the drug of abuse (Adams et al., 1969; Ferguson et 
al., 1969; Kayan et al., 1969). Tolerance shares a number of characteristics with learned 
associations, such as sensitivity to latent inhibition procedures (Siegel, 1977), and disruption 
by the administration of agents that prevent learning, such as antagonists at NMDA 
receptors (Trujillo and Akil, 1991). Furthermore, tolerance to drug effects can be reduced if 
the association between the drug and the environment is behaviourally extinguished prior to 
testing (Siegel, 1977).  Whether associative or non-associative, or both, drug tolerance can 
influence the magnitude of drug-seeking and taking behaviour by reducing the physical 
and/or hedonic effects of drug administration. 
Sensitisation seems, at first glance, to be the opposite of drug tolerance: 
sensitisation is the enhancement of the acute effects of drug administration, usually 
measured in terms of its effects on locomotor activity. As for drug tolerance, there has been 
debate in the literature concerning the psychological and neurobiological basis of 
sensitisation, which may not be a unitary phenomenon (Wise and Leeb, 1993). There is clear 
evidence that sensitisation can be conditioned (Badiani et al., 1997; Badiani et al., 2000; 
Vezina and Leyton, 2009), and that this conditioning depends upon dopaminergic 
transmission in the amygdala and nucleus accumbens (Pert et al., 1990). Sensitisation to the 
incentive motivational effects of drugs is the basis of another influential theory of addiction 
(Robinson and Berridge, 1993, 2000), which emphasises the importance of increased 
attention towards drug stimuli; this increase in attention to drug CSs has been observed for 
individuals addicted to nicotine (Clarke and Kumar, 1983; Hakan and Ksir, 1988; Stolerman et 
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al., 1973), opiates (De Vries et al., 1998; Lubman et al., 2000; Marinelli et al., 1998), cocaine 
(De Vries et al., 1998; Morgan and Roberts, 2004; Post et al., 1981; Reith, 1986; Shippenberg 
and Heidbreder, 1995) and amphetamine (Anagnostaras et al., 2002; Badiani et al., 1997; 
Camp and Robinson, 1988). Certainly, it has been argued that conditioned sensitisation can, 
in animals, increase the likelihood of subsequent drug-seeking behaviour (Piazza et al., 1990) 
and conditioned place preference (Shippenberg and Heidbreder, 1995). However, though an 
amphetamine sensitisation treatment regimen facilitates the formation of habitual 
responding for food (Nelson and Killcross, 2006; Nordquist et al., 2007) and promotes the 
escalation of cocaine-seeking (Ferrario and Robinson, 2007), several studies have indicated 
that behavioural, particularly locomotor, sensitisation is dissociable from subsequent 
‘addiction-like’ phenomena in preclinical models of the disorder, particularly compulsive 
drug use (Ahmed and Cador, 2006; Belin et al., 2008; Molander et al., 2011). The importance 
of conditioned sensitisation for addiction is, therefore, still a matter of debate, and a key 
question that remains to be answered is how tolerance or sensitisation processes come to 
dominate in a given context. One view (Belin et al., 2011; Belin et al., 2008) is that 
susceptibility to locomotor sensitisation reflects sensation-seeking, and so the risk of 
initiating drug use, while trait impulsivity predicts compulsive drug use. 
2.2.2. Instrumental associations 
INSTRUMENTAL, or OPERANT, CONDITIONING depends upon the consequences of an action to 
modify the likelihood of that action occurring in the future (Skinner, 1938; Thorndike, 1911). 
This distinguishes it from pavlovian conditioning, in which the contingency between the CS 
and the US is independent of the individual’s behaviour. Reinforcement of the instrumental 
response can occur through the learning of either positive or negative consequences of an 
action, and it is critically dependent on the contingency between the response and the 
reinforcer, the temporal contiguity between the response and the reinforcer, and the 
magnitude of reinforcement (Mackintosh, 1974). With extended training, the probability of 
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emitting the instrumental response can become independent of the outcome of the action, 
at which point the behaviour is deemed ‘habitual’. Habitual behaviour is hypothesised to be 
dominated by stimulus-response (S-R) representations, where the likelihood of eliciting the 
instrumental behaviour is determined by the presence of environmental CSs that were 
present when the action was learned (Dickinson, 1985), not the outcome of the action. 
Habitual behaviour can become compulsive, in that it is constantly repeated, even in the 
face of punishing or aversive outcomes; one of the key criteria of the DSM-IVR definition of 
substance abuse. In rodent models, compulsive behaviour can be assessed by actively 
punishing the drug-seeking response, for example, by presenting a CS associated with an 
aversive outcome, or by pairing some drug-seeking responses with footshock instead of drug 
(Belin et al., 2011; Belin et al., 2008; Everitt et al., 2008; Everitt and Robbins, 2005; Pelloux et 
al., 2007; Vanderschuren and Everitt, 2005). Animals that show compulsive drug-seeking 
behaviour will continue to make drug-seeking responses despite the negative consequences 
(see §2.2.2.3). 
 In summary, the initiation of drug-seeking and drug-taking behaviours, and relapse 
to these behaviours following abstinence, occurs through both positive and negative 
instrumental reinforcement, both of which are goal-directed. With extended experience 
drug-seeking and drug-taking can become compulsive and habitual (see §2.2.2.4). Thus, 
relapse becomes an automatic process elicited by the unconsciously perceived influence of 
drug-associated CSs. 
2.2.2.1. Positive reinforcement 
If the outcome of an instrumental response increases the likelihood of that behaviour 
recurring, then it is termed a ‘POSITIVE REINFORCER’. The capacity of addictive drugs to act as 
effective positive reinforcers does not necessarily mean that they are highly rewarding 
(Joseph et al., 2003), although in the early stages of addiction there may be a correlation 
Milton & Everitt 12 
between rewarding and reinforcing efficacy. According to the incentive sensitisation theory 
of addiction (Robinson and Berridge, 1993) there may be a dissociation between the neural 
systems underlying reward and reinforcement, designated as a difference between ‘liking’ 
and ‘wanting’ systems. Within this theory, a drug outcome could act as a powerfully strong 
reinforcer by activating the ‘wanting’ system, without having any effect on the ‘liking’ 
system and so not eliciting any hedonic response. Robinson and Berridge (1993) suggest that 
this is one of the characteristics of the later stages of addiction, which is highly compatible 
with the activation of compulsive, habitual responding in the maladaptive conditioning 
theories, where the action of drug-seeking becomes dissociated from the goal of 
experiencing the drug high (Everitt et al., 2008).  
2.2.2.2. Negative reinforcement 
Negative reinforcement occurs when the performance of an instrumental response 
decreases the likelihood of presentation of an aversive stimulus, or removes it, if it is already 
present in the environment. Therefore, as with positive reinforcement, the performance of 
the instrumental response increases; negative reinforcement should not be confused with 
PUNISHMENT (§2.2.2.3). 
Many addiction theories (Koob and Le Moal, 1997; Wikler, 1948) emphasise the 
importance of negative reinforcement in maintaining drug-seeking behaviour, and this form 
of ‘avoidance learning’ is closely linked to conditioned withdrawal (§2.2.1.1). Animals will 
work to avoid opiate withdrawal symptoms (Goldberg et al., 1971; Hellemans et al., 2006a; 
Kenny et al., 2006), though it has been suggested that the relative importance of negative 
reinforcement on relapse behaviour decreases as the individual completes drug 
detoxification in the early stages of abstinence. However, one way in which negative 
reinforcement may continue to control drug-seeking behaviour is via ‘incentive learning’ 
(Dickinson and Balleine, 1994), which has been shown to undergo consolidation and 
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reconsolidation within the amygdala (Wang et al., 2005; see §4). Incentive learning refers to 
the finding that negative reinforcement only becomes important in maintaining drug-seeking 
behaviour once an individual has experienced the withdrawal-relieving effects of drug-
taking; namely, the individual must have undergone incentive learning that, for example, 
heroin is a more effective positive reinforcer in the withdrawn state than in the non-
withdrawn state (Hutcheson et al., 2001). Hence, combined with conditioned withdrawal 
effects, it may be that negative reinforcement can maintain drug-seeking behaviour in the 
longer term, by ‘self-medicating’ the negative affective state of conditioned withdrawal or 
negative hedonic states. As stress produces a negative hedonic state, negative 
reinforcement may also link learning processes to the well-documented phenomenon of 
stress-induced relapse (Goeders and Guerin, 1994; Ramsey and Van Ree, 1993). 
2.2.2.3. Punishment  
Punishment reduces instrumental behaviour, as presentation of the negative outcome is 
contingent upon behaviour. This distinguishes it from negative reinforcement, in which the 
frequency of the instrumental response is increased by the removal of an aversive stimulus 
following the elicitation of the response.  
 Many of the traditional social responses to addiction are based upon punishment. 
However, consistent with the hypothesis of addiction involving habitual, compulsive drug-
seeking and drug-taking that is dissociated from the outcome of the instrumental action, 
punishment does not seem effectively to deter addicted individuals from drug use, at least in 
the long term. This has been empirically noted, as one of the key criteria for addiction in 
DSM-IVR is that the individual persists in drug-seeking and drug-taking behaviour despite 
adverse consequences (Table 1) and therefore, by definition addicted individuals will be less 
likely to modify their behaviour when threatened with prison or other punishments.  
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For this reason, punishment has been largely ineffective in helping individuals to 
relinquish their addiction, though it is likely to be effective at deterring casual users from 
drug use. Recent work has used this clinical criterion of addiction to derive more realistic 
animal models for addiction (Deroche-Gamonet et al., 2004; Economidou et al., 2009; 
Pelloux et al., 2007). In these animal models, individuals are allowed to seek or take cocaine 
before being screened on a number of behavioural criteria, including the capacity of 
punishment such as footshock delivery, to reduce drug-seeking or taking. In all of these 
studies, approximately 15-20% of individuals were found to be resistant to punishment, 
which is similar to the proportion of humans who, having been exposed to cocaine, are 
estimated to be vulnerable to addiction and, therefore, who take drugs despite negative 
consequences (Anthony et al., 1994). These animals are no less responsive to shock, and do 
not show persistent seeking of natural reinforcers such as sucrose; therefore, it is argued 
that this resistance to punishment models compulsive drug-seeking or taking behaviour 
(Pelloux et al., 2007). 
2.2.2.4. Stimulus-response associations (‘habits’) 
Positive reinforcement, negative reinforcement, and punishment are all examples of 
influences on instrumental action-outcome (A-O) associations since by altering an outcome, 
the instrumental behaviour is adjusted (e.g. responding more for a bigger and better positive 
reinforcer, or less when an outcome is devalued by punishment). These may be of greatest 
relevance for casual drug use, before habitual and compulsive responding for drug emerge 
(Everitt and Robbins, 2005). S-R associations will also form with behaviours associated with 
obtaining natural reinforcement (Dickinson, 1985) but usually take extensive ‘overtraining’ 
or situations in which a weak contingency between the action and its outcome is operating 
(for instance, interval schedules) in order to develop. The critical difference between natural 
reinforcers and addictive drugs has been suggested to be that addictive drugs bias 
instrumental responding away from mediation by A-O associations, towards S-R 
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representations. In addition to Everitt & Robbins (2005), Cardinal et al. (2002), Berke & 
Hyman (2000) and Hyman & Malenka (2001) have independently hypothesised that drugs of 
abuse bias individuals towards habitual responding, specifically via the dopamine-dependent 
‘stamping in’ of drug-associated memories. According to this view, the release of  dopamine 
in the targets of ventral tegmental neurons is a signal of prediction error in associative 
learning for natural reinforcers, and these increases in dopamine promote the plasticity 
associated with learning (Schultz et al., 1997). Addictive drugs and drug-associated cues 
consistently increase dopamine release in limbic and striatal structures (Carboni et al., 1989; 
Di Chiara and Imperato, 1988; Hurd and Ungerstedt, 1989; Kalivas and Duffy, 1990; 
Kuczenski and Segal, 1989), and thus it is hypothesised that the prediction error signal is 
always engaged during drug-taking behaviour, promoting pavlovian and habit learning 
(Redish et al., 2007; Wise, 2002). 
 This dependence of instrumental behaviour on S-R associations is significant for 
several aspects of addiction, including persistence of the behaviour despite adverse 
consequences, and the compulsive nature of drug-seeking. Firstly, because the S-R 
association does not incorporate a representation of the outcome, S-R associations are 
persistent despite changes in the value of the outcome, for example, when devalued. 
Secondly, because the drug-seeking response is elicited by environmental stimuli, S-R 
behaviour is no longer under the direct control of the motivational state of the individual, 
and instead is more dependent upon CSs present in the environment. The presentation of 
these CSs can automatically elicit drug-seeking behaviour that is divorced from the 
consequences of that behaviour and possibly elicited unconsciously (Tiffany, 1990).  
Habitual responding is not necessarily compulsive. Compulsive responding may be 
operationally defined as habitual behaviour that is constantly repeated despite negative 
consequences, insensitive to the devaluation of outcome and inflexible following changes in 
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the reinforcement schedule (Vanderschuren and Everitt, 2005). In short, while habits are 
automatic, involuntary behaviours that can be elicited by environmental stimuli, a 
compulsive habit is one in which the individual feels an urge that the behaviour must be 
performed, perhaps even despite its consequences. The emergence of compulsive habits has 
been hypothesised to be a key final stage event in the establishment of addictive drug-
seeking and taking (Everitt and Robbins, 2005). There is clear evidence from the rat 
literature that responding for addictive drugs, most notably cocaine, becomes both habitual 
and compulsive following extended access to the drug. Rats that have extensive cocaine 
(though not heroin - McNamara et al., 2010) self-administration histories are more likely to 
continue drug-seeking behaviour in the presence of conditioned stimuli that predict 
punishment (Vanderschuren and Everitt, 2004) or following punishment of the drug-seeking 
behaviour (Belin et al., 2008; Deroche-Gamonet et al., 2004; Pelloux et al., 2007) than rats 
that have more limited self-administration histories. Furthermore, there is evidence that 
habitual responding for both alcohol (Dickinson et al., 2002) and orally self-administered 
cocaine (Miles et al., 2003) is insensitive to gastric malaise-induced devaluation procedures 
that will prevent responding for natural reinforcement such as sucrose, clearly 
demonstrating that the response of drug-seeking had become independent of its outcome 
(though it was not demonstrated in these studies that responding had become compulsive). 
It has also been shown that while rats with limited cocaine self-administration histories are 
sensitive to devaluation of the ‘taking’ lever in the ‘seeking-taking task’ (Olmstead et al., 
2001; Zapata et al., 2010), rats with extended self-administration histories are insensitive to 
devaluation of the taking lever, indicating that drug-seeking behaviour has transitioned from 
being goal-directed to being habitual (Zapata et al., 2010). Finally, rats with extended 
cocaine self-administration histories also show inflexible behaviour, as they will continue to 
show drug-seeking behaviour in the presence of cues that explicitly signal that responding 
will not be reinforced (Deroche-Gamonet et al., 2004). This can be compared to the human 
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situation in which addicted individuals will continue to show inflexible drug-seeking, even 
when there is the threat of, or actual, punishment of such behaviour.  
2.3. Interim summary 
The formation of drug-associated memories profoundly influences behaviour in addiction, 
whether those are memories for environmental conditioned stimuli (CSs) associated with 
the drug, the instrumental actions underlying drug-seeking and drug-taking, or incentive 
learning that drug use during withdrawal relieves the negative symptoms of that withdrawal 
or stress. The aberrant engagement of psychological mechanisms normally operating to 
underlie adaptive behaviour towards natural reinforcers, such as food or sex, can lead to 
maladaptive, compulsive behaviour by which drugs may become valued above alternative 
reinforcers, despite the negative consequences of drug abuse. These psychological 
mechanisms underlying addiction are supported by discrete neurobiological substrates, and 
treatments for addiction in the future might be more effective if they are based upon not 
only an understanding of the psychological processes underlying the disorder, but also the 
areas or systems of the brain and the neurochemical systems that modulate their 
functioning in consolidating, reconsolidating and extinguishing these drug-related memories.  
 
3. NEURAL CIRCUITS UNDERLYING ADDICTION 
Although addiction to drugs is associated with changes throughout the brain, one of the key 
neural systems on which drugs of abuse act is the limbic corticostriatal circuitry, which is 
involved in motivation, reward, learning and memory. This circuitry is conserved across 
species, including humans, primates and rodents. Much of the research elucidating the 
neural circuits underlying addiction has made use of rodent models, which have been used 
extensively (see Sanchis-Segura and Spanagel, 2008, for review). A full review of the 
functions of the limbic corticostriatal circuitry is beyond the scope of this article; here we 
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focus on the key structures involved in mediating the effects of pavlovian CSs on behaviour, 
and the circuitry underlying instrumental learning.  
3.1. The ‘limbic’ corticostriatal circuitry and influences of drug CSs on behaviour 
The limbic corticostriatal system (Figure 1) encompasses ‘limbic’ cortical sites such as the 
amygdala and hippocampus, neocortical areas (particularly the prefrontal cortices) and the 
basal ganglia. The ultimate output of the system is through the basal ganglia (striatum and 
pallidum), which governs the selection of one action amongst alternatives (Graybiel, 1998; 
Grillner et al., 2005; Kropotov and Etlinger, 1999; Mink and Thach, 1991).  
 Among the key neural structures within the limbic corticostriatal circuitry relevant to 
drug addiction (Figure 1) are the amygdala, the hippocampus, the ventral striatum (including 
the nucleus accumbens) and the orbitofrontal cortex. Therefore, the general functions of 
these areas will be discussed, with particular reference to their neurochemical modulation 
(particularly by dopamine) and their importance for the psychological processes underlying 
addiction (see §2).  
3.1.1. The amygdala and hippocampus mediate CS-US and context-US associations  
Drug-associated CSs and contexts influence drug-seeking behaviour and relapse by 
maintaining drug-seeking and drug-taking behaviours, and by precipitating relapse in 
abstinent individuals (Arroyo et al., 1998; de Wit and Stewart, 1981; Glasner et al., 2005; 
Glautier, 1994; Meil and See, 1997; Robins et al., 1974; Sinha et al., 2000; Tomie, 1996). 
These drug CSs induce relapse readily in animal models of drug addiction (de Wit and 
Stewart, 1981; Shaham et al., 2003) and elicit drug craving in human addicts (Bonson et al., 
2002; Childress et al., 1999; Garavan et al., 2000; Grant et al., 1996). Furthermore, drug 
craving in human addicts and presentation of drug CSs to drug-experienced rats elicits 
functional activity or cellular and molecular changes in the limbic corticostriatal circuitry 
(Bonson et al., 2002; Boujabit et al., 2003; Childress et al., 1999; Garavan et al., 2000; Grant 
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et al., 1996; Schiffer et al., 2009; Thomas et al., 2003; Thomas and Everitt, 2001), suggesting 
that the neurobiological substrates underlying the motivational impact of drug-paired CSs is 
conserved across species. The amygdala and the hippocampus are important in mediating 
these associations. 
 The nuclei of the amygdala are critical for the representation of pavlovian CS-US 
associations. The amygdala consists of a number of interconnected subnuclei, often grouped 
into the corticomedial, central and basolateral divisions, each with different afferent and 
efferent projections (Pitkänen et al., 1997). The lateral and basolateral nuclei (together, the 
BLA) receive a number of sensory inputs, both highly processed inputs from the sensory and 
association cortices, and ‘raw’ inputs directly from the thalamus, whilst the central nucleus 
(CeN) receives the thalamic inputs, input from the sensory brainstem and some cortical 
inputs from the prefrontal and insula cortices (Li et al., 1996; McDonald et al., 1999; Rizvi et 
al., 1991; Turner and Herkenham, 1991). The involvement of the basolateral and the central 
amygdala in motivated behaviour has been the subject of extensive investigation, 
predominantly through the study of pavlovian conditioned fear. Although evidently very 
different from the appetitive associations that underlie addiction, many of the conclusions 
from the fear literature are also relevant to appetitive conditioning (Balleine and Killcross, 
2006). The amygdala encodes CS affective values via association with the US, with the BLA 
and CeN encoding sensory-specific and general motivational aspects of the CS-US association 
respectively. The corticomedial amygdala is particularly implicated in olfactory learning, but 
will not be considered further here. 
 The BLA has been shown to be necessary for the representation of sensory-specific 
affective CS-US associations (Balleine and Killcross, 2006; Cador et al., 1989; Holland and 
Gallagher, 2003), while the CeN is required for more generalised representations of the 
affective value of a CS. Thus, broadly speaking the BLA is required for sensory-specific 
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conditioned reinforcement and specific pavlovian-instrumental transfer (PIT), while the CeN 
is necessary for general PIT and pavlovian conditioned approach. The BLA is required for 
representation of the motivational value or sensory specific properties of conditioned 
reinforcers, for both natural (Blundell et al., 2001; Hatfield et al., 1996; Holland and 
Gallagher, 2003; Killcross et al., 1997; Lindgren et al., 2003; Schoenbaum et al., 1998; Setlow 
et al., 2002) and drug reinforcers (Di Ciano and Everitt, 2004a; Fuchs et al., 2005b; Fuchs and 
See, 2002; Meil and See, 1997; Yun and Fields, 2003), including under second-order 
schedules of reinforcement (Whitelaw et al., 1996). Lesions (Meil and See, 1997) and 
inactivation (Kantak et al., 2002) of the BLA prevent the reinstatement of cocaine-seeking 
behaviour in CS-induced models of relapse. BLA lesions also disrupt the cue-induced 
reinstatement of heroin-seeking behaviour (Fuchs and See, 2002), demonstrating the 
importance of the BLA in mediating CS influences on drug-seeking behaviour for different 
drug classes. Furthermore, the BLA has also been shown to be activated during conditioned, 
though not acute, withdrawal (Frenois et al., 2005; Lucas et al., 2008), and BLA lesions 
prevented a CS associated with morphine withdrawal from suppressing ongoing 
instrumental behaviour (Schulteis et al., 2000). This indicates that the BLA is important for 
mediating CS-US associations for aversive, as well as appetitive, reinforcers, consistent with 
its necessity for conditioned fear (Killcross et al., 1997; LeDoux et al., 1986; Maren et al., 
1996). 
The role of the CeN in drug-seeking behaviour is less well-established, but it is 
hypothesised that the CeN may be an important neural substrate for the incentive 
motivational properties of drug CSs, based on its involvement in PIT (Hall et al., 2001a; 
Holland and Gallagher, 2003) and conditioned approach towards CSs associated with food 
reinforcement (Parkinson et al., 2000). The capacity of the CeN to influence behaviour on 
the basis of general motivational state is also supported by evidence that activity in the CeN 
is required for stress-induced reinstatement (Erb et al., 2001; Ma et al., 2008). The CeN 
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appears critical for footshock stress-induced reinstatement of cocaine-seeking (McFarland et 
al., 2004) and morphine-seeking (Ma et al., 2008), and corticotrophin releasing factor (CRF) 
receptor antagonists (Erb et al., 2001) or α2-adrenergic receptor agonists (Erb et al., 2000; 
Yamada and Bruijnzeel, 2010) administered into the CeN reduce stress-induced 
reinstatement. 
Context-induced reinstatement of drug-seeking behaviour requires the 
hippocampus, similar to its role in contextual fear conditioning (Phillips and LeDoux, 1992; 
Selden et al., 1991). It is well-established that contexts previously associated with drug use 
can promote relapse to drug-seeking behaviour in human addicts (O'Brien et al., 1992) and 
in animals with an extensive history of drug self-administration (Bossert et al., 2006; Bossert 
et al., 2004; Bossert et al., 2007; Crombag et al., 2002; Crombag and Shaham, 2002; Fuchs et 
al., 2006; Fuchs et al., 2007; Fuchs et al., 2005a; Kearns and Weiss, 2007). In rodent models, 
inactivation of the dorsal hippocampus prevents the context-induced reinstatement of 
cocaine seeking (Fuchs et al., 2005) and inactivation of the dorsal hippocampus and BLA in a 
‘disconnection’ procedure also led to a reduction in context-induced reinstatement (Fuchs et 
al., 2007). It is hypothesised that the hippocampus represents the context as a CS, with the 
amygdala associating the hippocampal-encoded context with the affective value of the US; 
this is the case for contextual memories associated with aversive outcomes (Matus-Amat et 
al., 2007) and appetitive conditioning for natural (Ito et al., 2006) and drug reinforcers 
(Hitchcott and Phillips, 1997). 
3.1.2. The ventral striatum integrates motivational influences on behaviour 
The ventral striatum, in particular the nucleus accumbens (NAcb), was hypothesised in a 
now classic paper by Mogenson et al. (1980) to be the site at which affective or motivational 
information within the ‘limbic’ structures is integrated with the behavioural output systems; 
that it provides a ‘limbic-motor interface’. This view sees the nucleus accumbens as 
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important in mediating the influence of motivational states and pavlovian stimuli on 
appetitive, including instrumental, behaviour. The NAcb is subdivided into core (NAcbC) and 
shell (NAcbSh) subregions, which differ in terms of their connectivity and function (Heimer 
et al., 1991). The NAcbC receives inputs from the amygdala, insula, and the anterior 
cingulate, prelimbic and orbitofrontal cortices, and projects to the ventral pallidum, while 
the NAcbSh receives inputs from the amygdala, hippocampus and prefrontal infralimbic 
cortex, and in addition to the ventral pallidum projects to ‘limbic’ outputs such as the lateral 
hypothalamus (Heimer et al., 1997; Zahm, 1999; Zahm and Brog, 1992). The NAcbSh is an 
atypical area of the striatum (Heimer et al., 1997), and shares a number of characteristics 
with the central nucleus of the amygdala, including neurochemical modulation and afferent 
projections, leading to its inclusion within the ‘extended amygdala’ (Alheid et al., 1998; 
Alheid and Heimer, 1988). Furthermore, the NAcb shows neuroadaptations following drug 
experience, particularly changes in glutamatergic signalling (Kalivas et al., 2003; Moran et al., 
2005) that are hypothesised to increase the salience of drug-associated CSs and so their 
impact on behaviour (Kalivas, 2004). 
The functions of the NAcbC and NAcbSh are broadly divided, with the NAcbSh 
providing a conditioned ‘vigour’ to a response that is directed by the NAcbC (Ito et al., 2004). 
Supporting this view, the NAcbC has been shown to mediate the effects of cocaine-
associated CSs on instrumental behaviour, whilst the NAcbSh mediates so-called 
unconditioned stimulant drug effects such as locomotor activity (Parkinson et al., 1999) and 
UNCONDITIONED RESPONSES for non-drug reinforcers, such as ingestion and environmental 
exploration (Di Chiara et al., 1999; Kelley et al., 2005; Kelley and Berridge, 2002; Meredith et 
al., 2008). Thus, briefly (see Cardinal et al., 2003; Everitt and Robbins, 2005, for more 
extensive review) the NAcbC and NAcbSh are required for different influences on pavlovian 
CSs on behaviour; lesions of the NAcbC lead to deficits in conditioned reinforcement and 
general PIT (Hall et al., 2001a; Parkinson et al., 1999) while dopamine depletion within the 
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NAcbSh produces impairments in the expression of pavlovian conditioned approach 
(Parkinson et al., 2002) and outcome-specific PIT (Corbit et al., 2001). The necessity of the 
NAcb subregions for these behaviours depends on the connections to the different nuclei of 
the amygdala, with the NAcbC and the BLA constituting a functional circuit for conditioned 
reinforcement as shown by disconnection lesions  (Parkinson et al., 1999) and the NAcbSh 
interacting with the CeN and the anterior cingulate cortex to support behaviour such as 
conditioned approach (Parkinson et al., 2000). However, despite these differences, the 
NAcbC and NAcbSh are interconnected, suggesting that their functions are not fully 
independent (van Dongen et al., 2005). The NAcbC and NAcbSh are required for different 
aspects of drug-seeking behaviour, as revealed by studies using, for example, second order 
schedules of reinforcement. (For a more extensive review of the role of the nucleus 
accumbens in addiction, refer to Di Chiara, 2002; Kalivas and McFarland, 2003; Robbins and 
Everitt, 1996). 
In second-order schedules of reinforcement, animals respond for drug over long 
periods of time (delays to reinforcement) and their seeking responses are maintained by 
drug-associated CSs, acting as conditioned reinforcers. This procedure allows a dissociation 
of responding mediated by conditioned and unconditioned drug effects, as the drug is only 
delivered at the end of a seeking period, which is often defined by the passage of time (e.g. a 
fixed interval; Everitt and Robbins, 2000). Therefore, responding during the first, drug-
unaffected seeking period is maintained by the presence of drug-associated CSs, and is not 
confounded by the unconditioned effects of the drug on behaviour, whilst subsequent 
intervals, following drug delivery, allow a measure of the effect of the self-administered drug 
on instrumental seeking behaviour (Everitt and Robbins, 2000). Inactivation of the NAcbC, 
via local antagonism of glutamate receptors or selective lesion, resulted in greatly reduced 
cocaine-seeking during the first and subsequent intervals of a second-order schedule (Di 
Ciano and Everitt, 2001), but with no effect on cocaine-taking under continuous 
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reinforcement, suggesting that the NAcbC supports the capacity of conditioned reinforcers 
to maintain previously acquired drug-seeking behaviour. Furthermore, only NAcbC 
inactivation, not NAcbSh inactivation, reduced the reinstatement of drug-seeking behaviour 
by cocaine-associated CSs (Di Ciano et al., 2008; Fuchs et al., 2004). CS-evoked drug-seeking 
behaviour depends critically upon the connections of the NAcbC to the basolateral 
amygdala, as disconnection of the BLA and the NAcbC prevented drug-associated CSs from 
influencing drug-seeking behaviour (Di Ciano and Everitt, 2004b). 
Therefore, the connections between the NAcb and the amygdala form two types of 
functional circuit; one in which the general affective properties of a pavlovian CS can 
influence behaviour, depending upon the connection between the CeN and NAcbC (Hall et 
al., 2001; Parkinson et al., 1999; Parkinson et al., 2000b) and another that is required for 
sensory-specific CS-US representations to flexibly influence behaviour, depending upon the 
connection between the BLA and the NAcbC.  
3.1.3. The dorsal striatum is recruited as drug-seeking becomes a stimulus-response 
habit 
As described previously (§2.2.2.) instrumental associations can be either goal-directed 
(action-outcome, or A-O) or habitual (stimulus-response, or S-R). The learning of A-O and S-R 
associations depends upon different neural substrates; the prelimbic cortex and anterior 
dorsomedial striatum for A-O associations, and the infralimbic cortex and posterior 
dorsolateral striatum for S-R associations. (A full discussion of the role of the striatum in 
learning and addiction is beyond the scope of this review; see Balleine et al., 2009, and other 
articles in the same special issue for further information.) 
 Action-outcome behaviour depends upon a circuit encompassing the prelimbic 
region of prefrontal cortex (Balleine and Dickinson, 1998; Corbit and Balleine, 2003) and the 
dorsomedial striatum (Yin et al., 2005), along with other areas involved in the representation 
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of outcomes predicted by pavlovian stimuli, for example, the orbitofrontal cortex and 
basolateral amygdala (Baxter et al., 2000; Gallagher et al., 1999; Schoenbaum et al., 1998; 
Schoenbaum and Esber, 2010). By contrast, habitual behaviour depends critically upon the 
posterior dorsolateral striatum (Packard and McGaugh, 1996; Yin et al., 2006; Zapata et al., 
2010). Though separable, these neural circuits can operate in parallel, and it has been 
hypothesised (Mishkin et al., 1984) that during the early stages of instrumental learning, the 
cortex is necessary for the acquisition of instrumental responding but that following 
extensive training, the instrumental behaviour becomes habitual and more dependent on 
the dorsal striatum. This is a key component of the maladaptive conditioning theory of 
addiction (Everitt and Robbins, 2005).  
 Instrumental behaviour becomes increasingly more dependent on the dorsal 
striatum with extensive training (Knowlton et al., 1996; Yin et al., 2004) perhaps, it has been 
hypothesised (Everitt et al., 2008; Everitt and Robbins, 2005) via progressive recruitment by 
the spiralling dopaminergic circuitry of the midbrain (Haber et al., 2000; Figure 1). Both 
antagonism of dopamine receptors within the dorsal striatum with α-flupenthixol and, 
separately, inactivation of the dorsal striatum with an AMPA/kainate receptor antagonist 
disrupts well-established drug-seeking behaviour in rats (Vanderschuren et al., 2005). 
Furthermore, disconnection of the spiralling dopaminergic circuitry via a combined unilateral 
lesion of the NAcbC and a contralesional infusion of a dopamine receptor antagonist into the 
dorsal striatum reduced drug-seeking behaviour in rats that had previously undergone 
extensive cocaine self-administration training (Belin and Everitt, 2008). The strongest 
evidence supporting this hypothesis comes from the work of Zapata et al. (2010), which 
demonstrated that not only did extended training on a seeking-taking chain schedule for 
cocaine lead to habitual behaviour (measured by the failure to devalue the drug-taking 
response through contingency degradation) but also that transient inactivation of the 
posterior dorsolateral striatum reduced drug-seeking only when the drug-taking response 
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had been devalued. Although it has been argued that dopaminergic transmission within the 
dorsolateral striatum may be involved in drug reinforcement (Veeneman et al., 2012), much 
evidence (Belin and Everitt, 2008; Murray et al., 2011; Vanderschuren and Everitt, 2005; 
Zapata et al., 2010) suggests that there is a progressive recruitment of the dorsal striatum in 
mediating drug-seeking behaviour as it becomes habitual and compulsive. 
3.2. Interim summary 
Structures such as the amygdala and hippocampus process sensory and ‘limbic’ inputs, 
thereby allowing them to represent the sensory properties of drug-associated CSs and 
contexts respectively, with the amygdala mediating the motivational value of a particular CS. 
Projections from the amygdala and hippocampus to the nucleus accumbens core and shell 
subregions allows for these pavlovian CSs to influence instrumental behaviour, with separate 
but overlapping neural circuits underlying the psychological processes of conditioned 
reinforcement, pavlovian conditioned approach and pavlovian-instrumental transfer, all of 
which contribute to drug-seeking and taking. The development of habitual drug-seeking 
behaviour is associated with an increasingly dominant control by the dorsal striatum, which 
may be recruited by antecedent processing in limbic cortical-NAcbC circuitry (Everitt and 
Robbins, 2005). 
 
4. DRUG MEMORY RECONSOLIDATION: MECHANISMS AND IMPLICATIONS FOR 
TREATMENT 
As discussed in §2, the formation of addictive drug memories reflects the usurping of the 
learning and plasticity processes that normally underlie the learning of associations between 
environmental stimuli and natural reinforcers. The consolidation of drug-associated 
memories and the plasticity associated with addiction has been reviewed previously (Hyman 
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et al., 2006; Jones and Bonci, 2005; Kauer, 2004). The focus of this section will be on the 
neurochemical and molecular mechanisms of drug memory reconsolidation. 
4.1. Memory reconsolidation: an introduction 
The traditional and dominant view of memory is that it is stable and immutable following its 
initial consolidation (McGaugh, 1966). However, this view was challenged by the discovery of 
‘cue-dependent amnesia’ (Misanin et al., 1968; Schneider and Sherman, 1968), in which 
previously consolidated memories were found to be susceptible to disruption if amnestic 
agents were given in conjunction with memory retrieval. Following two prominent failures to 
replicate the finding of cue-dependent amnesia (Dawson and McGaugh, 1969; Gold and 
King, 1972), this research area was relatively quiescent until reawakened by Nader and 
colleagues in the early part of this century. Nader et al. (2000) showed that presentation of a 
pavlovian, fear-associated CS, in conjunction with infusions of the protein synthesis inhibitor 
anisomycin directly into the basolateral amygdala, led to the disruption of the fear memory 
long after the memory had consolidated. Furthermore, the amnesia was dependent upon 
memory reactivation achieved by presentation of the CS, and was persistent. Subsequently, 
this led to the evolution of the ‘cue-dependent amnesia’ hypothesis (Lewis, 1979) into the 
‘memory reconsolidation’ hypothesis (Nader, 2003). Memory reconsolidation theories posit, 
like memory consolidation theories, that following memory consolidation the memory 
enters a stable state that is persistent, and not susceptible to disruption. However, in 
contrast to memory consolidation theories, the reconsolidation hypothesis states that the 
consolidated memory can return to a short-lived, labile state through retrieval of that 
memory. Therefore, a memory cycles between ‘active’ and ‘inactive’ states depending upon 
whether it has recently been retrieved (Nader, 2003), when it enters the ‘active state’ 
(Lewis, 1979). 
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 The molecular and neurochemical mechanisms of memory reconsolidation have 
been reviewed previously (Milton and Everitt, 2010; Tronson and Taylor, 2007) and so will 
not be considered further in detail here. Instead, we will focus on evidence that the 
pavlovian and instrumental associations discussed in §3 reconsolidate. 
4.2. Pavlovian drug memory reconsolidation 
Studies of drug memory reconsolidation have almost exclusively focused on the 
reconsolidation of the pavlovian memories that underlie the maintenance of drug-seeking, 
and the long-term propensity to relapse. These associations can be assessed in rodents 
through many different behavioural procedures which model the psychological processes of 
conditioned reinforcement, CONDITIONED MOTIVATION, conditioned approach and conditioned 
withdrawal either in isolation, or in combination. In isolating specific psychological 
processes, these procedures allowed a greater understanding of the association in memory 
that is undergoing reconsolidation, both in terms of the animal’s predicted behaviour if 
amnesic, and in terms of neural substrates. However, these tasks, inspired by animal 
learning theory, are not fully representative of the clinical context in which drug memories 
influence the addiction cycle, and so it is advantageous to combine these psychologically 
specific tasks with others that translate more readily to addiction and relapse in a clinical 
population.  
4.2.1. Pavlovian CS-drug memories assessed using conditioned place preference (CPP) 
Conditioned place preference (CPP) is a widely used procedure used to measure the 
motivational properties of addictive drugs. In this procedure, the rats receive experimenter-
administered injections of drug, and are confined in the ‘paired’ compartment of a two- or 
three-compartment apparatus. On alternate training sessions, the animals are injected with 
an equivalent volume of saline, and are placed in the ‘unpaired’ compartment of the 
apparatus. Training typically requires 8 injections in total (4 drug and 4 saline). The drug-
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conditioned place preference is subsequently assessed by allowing the rats to move 
throughout the whole apparatus, with the time spent on the paired and unpaired sides being 
used to assess the reinforcing properties of the drug.  
 This procedure is quickly and easily learned, though it has some interpretational 
constraints. Firstly, it is not clear which psychological processes underlie place preference at 
test: a preference for the paired side could be supported by a number of learned 
associations, and it is not clear how all of these contribute to the expression of the 
preference. The second difficulty of interpretation in conditioned place preference 
procedures is the reliance on experimenter-administered drugs, which does not model the 
instrumental drug self-administration characterising addictive drug use in humans. 
Furthermore, because of the small number of pairings between the addictive drug and the 
paired side in the conditioned place preference procedure, this does not reflect the extent of 
pavlovian conditioning that occurs between environmental conditioned stimuli and the 
effects of drug in human addicts, who have an extensive history of drug use and therefore 
many pairings of CS and US. 
 Despite these interpretational challenges, the CPP procedure has been used 
extensively and successfully to investigate the neurochemical basis of drug memory 
reconsolidation. One of the original demonstrations that drug memories reconsolidate used 
this procedure; Miller and Marshall (2005) demonstrated that the administration of an 
inhibitor of the intracellular protein kinase ERK (extracellular signal-regulated kinase) in 
conjunction with memory retrieval, could prevent the expression of a place preference 
previously conditioned to cocaine at subsequent tests, conducted 24hrs and 14 days 
following the treatment. Since this original demonstration, it has been established that the 
memories underlying conditioned place preference for drugs other than cocaine also 
reconsolidate, including CS-amphetamine (Sadler et al., 2007) and CS-morphine (Milekic et 
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al., 2006; Robinson and Franklin, 2007a, b, 2010; Valjent et al., 2006) memories, both of 
which are susceptible to disruption with amnestic agents. 
 The reconsolidation of the memories underlying drug CPP depends upon protein 
synthesis (Milekic et al., 2006; Robinson and Franklin, 2007b; though see also Yim et al., 
2006) and the activation of intracellular signalling cascades, such as those mediated via 
extracellular signal-related kinase (ERK; Valjent et al., 2006). These are, in turn, most likely 
activated by signalling at glutamatergic and adrenergic receptors, as the reconsolidation of 
the memory association(s) underlying CPP is blocked by the administration of either NMDAR 
antagonists (Brown et al., 2008; Itzhak, 2008; Itzhak and Anderson, 2007; Sadler et al., 2007; 
Zhai et al., 2008) or β-adrenergic receptor antagonists (Bernardi et al., 2006; Bernardi et al., 
2009; Fricks-Gleason and Marshall, 2008; Robinson and Franklin, 2007) in conjunction with 
memory reactivation. Most studies of CPP memory reconsolidation have relied on the 
systemic administration of amnestic agents, though reconsolidation of these memories has 
been shown to depend more specifically on β-adrenergic signalling in the BLA (Bernardi et 
al., 2009), ERK-mediated signalling in the NAcbC (Miller and Marshall, 2005) and expression 
of the plasticity-related immediate early gene, zif268, in the basolateral amygdala and the 
nucleus accumbens core (Théberge et al., 2010). zif268 is expressed following memory 
retrieval (Hall et al., 2001b; Thomas et al., 2003; Thomas et al., 2002) and has been 
extensively implicated in the reconsolidation process (Bozon et al., 2003; Hellemans et al., 
2006; Lee, 2008; Lee et al., 2005; Lee et al., 2004).  
4.2.2. Pavlovian CS-drug memories assessed by isolating psychological associations 
Like the memories underlying drug CPP, the memories underlying the capacity of cocaine 
CSs to act as conditioned reinforcers, measured through the ‘acquisition of a new 
instrumental response’ procedure (Mackintosh, 1974), depend upon protein synthesis and 
the expression of zif268 within the BLA (Lee et al., 2005). The expression of zif268 required 
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for the reconsolidation of CS-cocaine memories is driven by signalling at NMDARs, since 
antagonism at NMDARs with D-APV prevents not only the CS from acting as a conditioned 
reinforcer subsequently, but also reduces the expression of Zif268 protein within the BLA 
(Milton et al., 2008a). This requirement for zif268 activity to promote the reconsolidation of 
the memory underlying conditioned reinforcement is restricted to the BLA, since knockdown 
of zif268 in other structures, such as the nucleus accumbens core (NAcbC), in conjunction 
with memory reactivation had no subsequent effect on the conditioned reinforcement 
memory (Théberge et al., 2010). Note, however, that the memories underlying CPP, and 
those specifically underlying conditioned reinforcement have different requirements for 
zif268 signalling during reconsolidation. 
 Though much of the work investigating the reconsolidation of specific psychological 
processes related to pavlovian memories has focused on conditioned reinforcement, there is 
some evidence that the CS-drug memories underlying conditioned motivation and 
conditioned approach also reconsolidate. The reconsolidation of CS-alcohol memories 
underlying conditioned approach as measured in an autoshaping procedure, and 
conditioned motivation as measured by pavlovian-instrumental transfer (PIT) depend upon 
signalling at the NMDAR, but not signalling at β-adrenergic receptors (Milton et al., 2011). 
The independence from β-adrenergic receptor signalling mechanisms of reconsolidation for 
the pavlovian associations underlying conditioned motivation and conditioned approach is 
very different from the disruption of the reconsolidation of the memory underlying 
conditioned reinforcement with the β-adrenergic receptor antagonist propranolol, for both 
CS-cocaine (Milton et al., 2008b) and CS-alcohol (Schramm et al., unpublished results) 
memories. 
 Finally, although there has been much less investigation of the reconsolidation of 
conditioned withdrawal and conditioned sensitisation, there is evidence that these 
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associations also reconsolidate.  It has been demonstrated that the memories underlying 
conditioned withdrawal reconsolidate within the BLA in a zif268-dependent manner 
(Hellemans et al., 2006) and that the reconsolidation of the memory underlying 
contextually-conditioned locomotor sensitisation to cocaine can be disrupted by the 
administration of anisomycin in conjunction with retrieval (Bernardi et al., 2007). To date, no 
work has been conducted on the reconsolidation of the memories underlying conditioned 
tolerance. This is a research area that warrants further investigation, especially with regard 
to incentive learning about drugs of abuse. 
4.2.3. Pavlovian CS-drug memories assessed via translational ‘relapse’ models 
There are two translationally relevant models of drug CS-induced relapse that have been 
used extensively in drug addiction research: ‘extinction-reinstatement’ (de Wit and Stewart, 
1981) and reinstatement following enforced abstinence (Lu et al., 2005; Shaham et al., 
2003). These are procedurally similar in that animals are trained to make an instrumental 
response to receive (usually intravenous) drug and presentations of a pavlovian CS. 
Following training, animals either undergo extinction training, in which instrumental 
responses are not reinforced with the drug or the CS, or ‘enforced abstinence’, in which they 
are not returned to the operant chamber for a specified length of time. Following these 
manipulations, the animals are subsequently tested for the reinstatement of instrumental 
responding when the drug CS, though not the drug, are once again made contingent upon 
instrumental responding.  
 Typically, disruption of CS-drug memory reconsolidation as assessed in these models 
does not impair the instrumental responding for drug itself – the ‘action-outcome’ 
association – but rather, it reduces the ability of the drug CS to maintain and enhance 
instrumental responding. This reduction in CS-maintained instrumental responding has been 
observed following several different manipulations at reactivation, including zif268 
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knockdown with antisense oligodeoxynucleotides (Lee et al., 2006a), PKA inactivation 
(Sanchez et al., 2010), NMDAR antagonism (Milton et al., 2008a; von der Goltz et al., 2009) 
though, interestingly, not β-adrenergic receptor antagonism for cocaine memories (Milton 
and Everitt, 2009), though β-adrenergic receptor antagonism at retrieval of alcohol cues 
does appear to reduce subsequent CS-elicited drug-seeking for alcohol (Wouda et al., 2010). 
These differences may reflect the differential dependence of behavioural procedures used to 
model addiction on the processes of conditioned reinforcement, conditioned motivation and 
conditioned approach. As these pavlovian ‘routes to relapse’ depend upon the BLA and CeN 
to differing degrees (see Milton and Everitt, 2010, for review), we hypothesise that the 
apparent discrepancies in the effects of β-adrenergic receptor antagonism on drug memory 
reconsolidation may be due to differences in β-adrenergic receptor expression across the 
BLA and CeN. 
4.3. Instrumental drug memory reconsolidation 
Compared to studies of pavlovian memory reconsolidation, there is little published work on 
the reconsolidation of instrumental memories. This can be attributed, at least in part, to an 
influential paper that reported that instrumental memories do not reconsolidate (Hernandez 
and Kelley, 2004). However, instrumental behaviour can be mediated through either goal-
directed, action-outcome associations, or habitual stimulus-response associations 
(Dickinson, 1985); both of which depend upon different neural circuitry. Therefore, 
disruption of one association underlying instrumental behaviour would not necessarily lead 
to a subsequent reduction in that behaviour at test; if, for example, the reconsolidation of a 
stimulus-response association was disrupted, habitual behaviour might be reduced, but if 
the animal still valued the outcome, then the action-outcome association might compensate 
for the disrupted S-R association. It is therefore important to distinguish between these 
associations when attempting to disrupt their reconsolidation. 
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 One method of distinguishing between behaviour mediated via action-outcome 
associations and stimulus-response associations is to design a test in which the two types of 
behaviour are dissociable. Packard and McGaugh (1996) used such a procedure, training rats 
to run to a sucrose-reinforced arm in a T-maze. This behaviour could be supported by an 
action-outcome association that depended on the location of the sucrose in space – a ‘place’ 
representation – or by a stimulus-response association through which the sucrose was 
located relative to the start arm. By rotating the maze 180
o
, it is possible to separate the 
responses mediated by each representation (Figure 2a).  As would be predicted from 
theoretical perspectives on habit learning (Dickinson, 1985), limited training produced 
behaviour that was primarily driven by an action-outcome association, with more extensive, 
overtraining producing an increased reliance on stimulus-response associations. Packard & 
McGaugh (1996) also demonstrated that the action-outcome representation required 
activity in the dorsal hippocampus, while stimulus-response associations required activity in 
the posterior dorsolateral striatum, consistent with other studies of the neural basis of 
‘habitual’ S-R behaviour (Yin et al., 2004). 
 Retrieval of the stimulus-response memory in the T-maze procedure was associated 
with an increase in the expression of Zif268 (Figure 2b; Milton et al., unpublished results). 
Animals were trained extensively on the T-maze task over 14 days, and subsequently given a 
probe test in which the maze was rotated 24 hours after the last training session. Brains 
were harvested either 2 or 6 hours later, and assessed for expression of Zif268 in four 
striatal regions. This analysis revealed that animals that had shown the S-R association-
mediated behaviour in the probe test had increased levels of Zif268 expression specifically in 
the posterior dorsolateral striatum relative to animals showing the A-O association-
mediated behaviour at test. This increase was evident in the brains that had been harvested 
2 hours following the probe test, but not for those collected 6 hours following the probe 
test. This is consistent with previous studies showing that the knockdown of Zif268 
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expression 6 hours following memory retrieval does not prevent reconsolidation (Lee et al., 
2006a). Other striatal areas (including the anterior dorsomedial striatum) did not show a 
reliable increase in Zif268 expression (Figure 2b). While correlative, these preliminary results 
suggest that, like pavlovian memories (Hall et al., 2001b; Thomas et al., 2002), the 
expression of zif268 increases following the retrieval of at least one type of instrumental 
memory. Whether Zif268 is required for the reconsolidation of S-R habit memories, as it is 
for the reconsolidation of pavlovian memories (Bozon et al., 2003; Hellemans et al., 2006; 
Lee et al., 2005; Lee et al., 2004; Lee et al., 2006a; Théberge et al., 2010), clearly warrants 
further study.  
4.4. Interim summary 
The disruption of memory reconsolidation may provide a new form of therapy for treating 
drug addiction. To date, most of the preclinical work has focused upon disrupting pavlovian 
CS-drug associations, so as to reduce their propensity to precipitate relapse and to maintain 
drug-seeking behaviour. These drug CSs are remarkably persistent and resistant to extinction 
(Di Ciano and Everitt, 2004a), so disruption of the ‘three routes to relapse’ through targeting 
reconsolidation should provide a method for reducing the risk of relapse in the long term 
(Milton and Everitt, 2010). 
 Less studied has been the disruption of the reconsolidation of the S-R memories 
that underlie drug-seeking in the later stages of the disorder. If drug-seeking behaviour could 
be returned to being goal-directed following an extensive drug self-administration history, 
then this would represent a major step forward in the treatment of drug addiction; this 
could potentially allow long-term drug addicts to once again gain control of their behaviour. 
Should this be possible, then abstinent addicts should be able to use legal drugs (e.g. 
alcohol) recreationally without a lapse converting into a full relapse; something that has 
been very difficult to achieve with currently available treatments for addiction. 
Milton & Everitt 36 
5. ALTERNATIVE TREATMENT STRATEGIES FOR ADDICTION 
Understanding the psychological and neural mechanisms underlying addiction should 
ultimately lead to the development of treatments for the disorder. However, though they 
work with some success, the current therapies available for addiction – pharmacotherapy 
and behavioural treatments – do not target one of the major underlying causes of addiction, 
namely, the maladaptive associations that underlie the propensity to seek and take drug, or 
to relapse following abstinence. Treatments based upon the disruption of drug memory 
reconsolidation or, perhaps, the enhancement of drug memory extinction, could provide a 
means by which these memories could be disrupted, and the risk of relapse markedly 
reduced.  
5.1. Comparison to existing treatment strategies 
Treatments for addiction have been in development since the disorder was first recognised, 
ranging from Sigmund Freud’s unsuccessful attempts to treat morphine addiction with the 
administration of cocaine (reviewed in Streatfeild, 2007) to maintenance-harm reduction 
treatments such as methadone or nicotine patches, and behavioural treatments such as 
cognitive behavioural therapy (CBT). The methods of action of currently available treatments 
vary markedly – from managing symptoms to providing coping strategies – but unlike the 
proposed reconsolidation-based treatments, none of the currently available treatments 
have ever attempted to disrupt the maladaptive memory associations that underlie relapse. 
One interesting novel type of treatment, however, aims to reduce the impact of CS-drug 
memories on behaviour by facilitating and generalising their extinction; this will also be 
considered in this section. 
5.1.1. Medication-based therapies 
Substitution therapies are one of the most widely used methods to reduce harm in 
addiction, by maintaining individuals on a safe and clean drug supply that provides an 
Milton & Everitt 37 
alternative treatment to establish abstinence. These can take the form of either drug 
replacement therapies which are designed to reduce withdrawal symptoms, such as 
methadone and buprenorphine for opiate addiction, or nicotine patches for cigarette 
smokers, or medications to reduce the anxiety or anhedonia associated with drug 
withdrawal, as in the case of treating cocaine-dependent subjects early in withdrawal with 
antidepressants (McElroy et al., 1989). Drug replacement therapies have shown success in 
preventing relapse, particularly to drugs associated with a physiological withdrawal 
syndrome on the cessation of use.  
 Another way in which medication-based therapy can be applied to the treatment of 
addiction is to reduce ‘craving’ for drugs of abuse.  A number of compounds, including 
agonists at GABAB receptors and antagonists at the D3 subtype of dopamine receptor, are in 
preclinical development as anti-craving treatments (Brebner et al., 2002; Di Ciano et al., 
2003; Economidou et al., 2011; Pilla et al., 1999; Tyacke et al., 2010) and may provide a way 
of reducing self-administration of psychostimulants. Clinical trials of compounds targeting D3 
dopamine receptors are underway (see Heidbreder and Newman, 2010, for review). 
Furthermore, the μ opiate receptor antagonist naltrexone has been used successfully to 
reduce craving for a number of drugs of abuse in the clinical situation. Naltrexone has been 
shown to reduce CS-induced reinstatement to alcohol-seeking behaviour (Liu and Weiss, 
2002), to reduce ‘binge drinking’ (Ji et al., 2008; Simms et al., 2008) in rodent models of 
alcoholism, and to prevent lapses from escalating into relapses in abstinent human 
alcoholics (Rösner et al., 2008). Naltrexone has also been shown to prevent craving for 
cocaine: it has been shown to reduce CS-induced (Burattini et al., 2008) and cocaine-induced 
(Gerrits et al., 2005) reinstatement of cocaine-seeking in rats, in addition to reducing cocaine 
self-administration in monkey and rodent models (Corrigall and Coen, 1991; Mello et al., 
1990). This suggests that drugs active at μ opiate receptors, such as naltrexone, may have 
potential as a more general ‘anti-craving’ drug, rather than specifically reducing craving to a 
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particular drug of abuse (e.g. varenicline reducing craving for nicotine - see Foulds et al., 
2006, for review). 
 An alternative use of medication in preventing relapse to drug addiction has been to 
induce an aversive state; for instance, the use of disulfiram in treating alcoholics. Disulfiram 
induces a profound sensitivity to the negative effects of alcohol by blocking the action of the 
liver enzyme acetaldehyde dehydrogenase (Deitrich and Erwin, 1971). As acetaldehyde is a 
major contributor to the ‘hangover’ symptoms (e.g. flushing of the skin, accelerated heart 
rate, nausea, vomiting) felt after excessive intake of alcohol, disulfiram effectively induces a 
‘hangover’ state rapidly (5 – 10 minutes) after the intake of alcohol, that can last from 30 
minutes to several hours. Disulfiram is thus effectively a punishment for alcohol intake, 
inducing a central aversive state. However, as discussed previously (§2.2.2.4.) habitual 
behaviour mediated by S-R associations is insensitive to devaluation; therefore, it might be 
predicted that the devaluation of alcohol with disulfiram in compulsive, habitual alcoholics 
would be ineffective in reducing drug-seeking, just as devaluation of a food reinforcer with 
overfeeding or the induction of gastric malaise with lithium chloride is ineffective at reducing 
habitual food-seeking. Thus, the treatment of addiction via punishment of drug-seeking and 
–taking behaviour has generally not been shown to be successful in human addicts or animal 
models (Pelloux et al., 2007) and the negative effects of disulfiram are usually insufficient to 
prevent relapse to alcohol self-administration in human addicts (Krampe et al., 2006).  
Medication-based treatments for addiction, though showing some success, face 
some difficulties. Firstly, all require long-term treatment compliance to be effective, and this 
is often difficult to achieve with individuals being treated for addiction on an outpatient 
basis due to issues of patient retention and medication compliance (Kampman et al., 2006). 
This is particularly problematic with medications that have undesirable side effects (even if 
these are central to the treatment, as for disulfiram) because this reduces the motivation of 
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the individual to continue with the treatment. However, even if medication compliance was 
possible to achieve, there are a further two challenges that a reliance on medication-based 
therapies would produce. One is the expense of maintaining addicts on the medication, and 
the other is that the regular use of medication would perpetuate the ‘drug addict’ image, 
continuing the stigmatisation associated with addiction. These negatives could be avoided 
by directly targeting the maladaptive CS-drug memories. 
5.1.2. Behavioural therapies 
A number of behavioural therapies are available for the treatment of addiction, including 
individual- (contingency management, cognitive behavioural therapy, extinction therapy) 
and group-based therapies (multidimensional family therapy, the “12 steps”). Here we will 
focus on individual-based therapies. 
5.1.2.1. Contingency management 
Contingency management is a type of behavioural therapy that has shown moderate 
success. Under this scheme addicts are rewarded for maintaining abstinence by, for 
example, receiving shopping vouchers in return for drug-free urine samples (Higgins et al., 
1991). Contingency management has been demonstrated to reduce drug use for cocaine 
(Petry et al., 2004), heroin (Silverman et al., 1996) and marijuana (Budney et al., 2000), at 
least in the short-term. It has been noted (Carroll and Onken, 2005) that contingency 
management is limited by a number of factors, including the weakening of its effects 
following the end of the treatment. Coupled to the high costs of providing the incentives 
that underlie this treatment, a long-term maintenance on contingency maintenance therapy 
would be difficult. This type of therapy is also unpopular with the general public, as reflected 
by the responses to the introduction of contingency management as a therapy for drug 
addiction in the UK National Health Service (McCrae, 2007). 
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 Contingency management was introduced as an alternative to the ‘punishment’ 
approach (prison and enforced detoxification) of treating addiction, which has been more 
traditionally favoured by society. However, there is a ‘substantial proportion’ of addicts who 
do not respond to contingency management as a form of therapy (Carroll and Onken, 2005). 
This may be because contingency management does not work on those that already show 
increased time spent in pursuit of drug in comparison to other natural and social reinforcers, 
as is part of the criteria for substance dependence according to DSM-IV and ICD-10 (Table 1). 
In these users there may be a short term effect of novelty of the shopping voucher 
reinforcer, but this will ultimately become degraded in comparison to the reward of the 
addictive drug, as did other aspects of the individual’s life as the addiction developed. As 
with other addiction therapies, contingency management does not treat the underlying 
cause of the addiction, and in a number of addicts is not effective at all (Carroll and Onken, 
2005). 
5.1.2.2. Cognitive behavioural therapy 
Cognitive behavioural therapy (CBT) is designed to help addicts recognise, avoid and cope 
with situations in which they are most likely to use drugs. Part of the procedure is based on 
the theories of Tiffany (1990) as addicts are taught consciously to monitor their behaviour in 
order to avoid the execution of the ‘automatic’ behaviour of drug-taking. The avoidance of 
situations in which the addict is likely to take drug is based upon the knowledge that 
environmental CSs and contexts increase the probability of drug-seeking and drug-taking 
behaviour, whether through the induction of ‘craving’ or the direct activation of the limbic-
corticostriatal circuitry involved in compulsive drug-seeking and drug-taking behaviour. 
Certainly it appears that cognitive behavioural therapy can have effects on the limbic 
corticostriatal circuitry, as when it is used to treat clinical depression, functional imaging 
studies show that the activity of the corticolimbic circuitry is modulated similarly to the 
effects of anti-depressant drugs (Goldapple et al., 2004). 
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 A subset of cognitive behavioural therapy is extinction or ‘exposure’ therapy, in 
which addicted individuals are presented with environmental cues that have previously been 
paired with the opportunity to self-administer drug, but are no longer reinforced during 
therapy (O'Brien et al., 1990). This type of treatment is informed by the preclinical literature: 
‘extinction’ therapies aim to achieve the devaluing of the CS-drug association by degrading 
the reinforcement contingency, creating a competing ‘CS-no drug’ association, so that CSs 
will no longer elicit compulsive drug-seeking behaviour (or ‘craving’). However, it has been 
commented (Conklin and Tiffany, 2002; Torregrossa et al., 2010) that extinction therapies 
generally do not take into account the highly context-specific nature of extinction learning 
(Bouton, 2002; Bouton and Swartzentruber, 1991). Memory extinction is hypothesised to be 
context specific, whereas the original, conditioned association is not (Bouton and Bolles, 
1979), and therefore the original association will tend to reinstate following exposure to 
novel contexts or the context in which the original association was trained (Bouton and 
Bolles, 1979)  as well as spontaneously recovering over time (Brooks and Bouton, 1993; 
Pavlov, 1927). Findings of reinstatement and renewal are common in the animal learning 
literature, meaning that the benefits of this type of therapy tend to be limited to the clinical 
context and are not sustained in the outside world (Conklin and Tiffany, 2002). Though cue-
exposure therapy has been applied to addiction with limited success (see Conklin and 
Tiffany, 2002, for review), there is scope for improvement (Nic Dhonnchadha and Kantak, 
2011; Torregrossa et al., 2010).  
5.2. ‘Facilitated extinction’ techniques 
Much work has focused on facilitating the formation and generalisation of extinction 
memories using pharmacotherapy; for instance, the NMDAR partial agonist D-cycloserine 
(DCS). DCS potentiates extinction learning in rodent models (Ledgerwood et al., 2003; Lee et 
al., 2006b; Walker et al., 2002) and may enhance the generalisation of extinction learning. In 
rats conditioned to fear a CS in two different contexts, extinction in one context under DCS 
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reduced freezing not only in the extinguished context, but also in an alternative, non-
extinguished context (Ledgerwood et al., 2005), suggesting that the administration of DCS 
may produce a generalisation of extinction that would overcome the difficulties of using 
‘cue-exposure’ therapies in the clinic, particularly the phenomena of renewal and 
reinstatement. Indeed, in a small clinical trial of height-phobic patients, administration of 
DCS in conjunction with virtual reality exposure to heights reduced fear for at least 3-months 
following the treatment (Davis et al., 2006).  
 D-cycloserine has also been applied to rodent models of addiction. DCS facilitates 
the extinction of a place preference previously conditioned to cocaine (Thanos et al., 2009) 
or alcohol (Groblewski et al., 2009). DCS has also been shown to enhance the extinction of 
instrumental alcohol-seeking behaviour in a rodent extinction-reinstatement model 
(Vengeliene et al., 2008), though it is difficult to generalise these findings to the clinical 
situation, where human addicts do not make unreinforced instrumental drug-seeking and 
drug-taking responses as part of their therapy. More straightforward to translate to the 
clinic is the finding that drug-CS extinction, in a preclinical behavioural procedure designed 
to model human cue exposure therapy, is facilitated by DCS, and reduces subsequent 
instrumental drug-seeking behaviour in both the extinction context, and a non-extinguished 
alternative context (Torregrossa et al., 2010). However, the behavioural parameters used in 
conjunction with DCS are extremely important; when given in conjunction with short cue re-
exposure sessions, DCS facilitates the reconsolidation of the CS-drug memory (Lee et al., 
2009), i.e. will actually strengthen the memory, thus potentially worsening treatment 
outcome. This dependence on the extent of the cue re-exposure session may reconcile the 
apparently conflicting findings that DCS enhances cue-reactivity in cocaine-dependent 
subjects (Price et al., 2009) while reducing reactivity in nicotine-dependent subjects (Santa 
Ana et al., 2009). 
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 Despite the promising results with D-cycloserine, some investigators have suggested 
that treatments that avoid pharmacotherapy might be more useful in treating addiction. 
Some recent work suggests that it might be possible to facilitate extinction without the use 
of psychoactive drugs. It has been found that if extinction learning occurs within a short time 
‘window’ following memory reactivation, there is an apparently persistent amnesia that 
does not renew, reinstate or spontaneously recover, which is observed at least for fear 
memories in rodents (Monfils et al., 2009). This facilitated extinction effect is also seen in 
human subjects trained on a fear conditioning task (Schiller et al., 2010). However, these 
findings have not always been replicable (Chan et al., 2010) and to date, have not been 
applied to CS-drug memories, which can be remarkably persistent and resistant to extinction 
procedures (Di Ciano and Everitt, 2004a). 
5.3. Alternative treatment strategies: comparison to memory-disruption techniques 
There are four obstacles to the development of addiction therapies – (i) patient retention in 
the programme, including medication compliance, (ii) the expense of long-term 
maintenance on a treatment programme, (iii) the continued stigmatisation of the addict 
acting as a barrier towards developing a new, drug-free life, and (iv) the effectiveness of the 
treatment when the individual returns to environments previously paired with drug-taking 
behaviour. The first three problems arise primarily out of therapies that attempt to treat the 
symptoms, and not the underlying causes, of relapse, and the last because of problems in 
the strength of competing associations compared to the association underlying compulsive 
drug-taking behaviour. Therapies based upon the disruption of memory reconsolidation or 
the facilitation of extinction might avoid or minimise most of these obstacles to successful 
treatment. The medication requirement of reconsolidation-based therapy would be much 
less than the regular dosing or therapy sessions that are currently required in relapse 
prevention treatments and, as a reconsolidation-based treatment would not require daily, 
prophylactic medication of the individual in order to avoid relapse, it should provide a more 
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cost-effective solution to the treatment of addiction than substitution therapies or 
contingency management. The few treatment sessions required – the preclinical literature 
suggests that the disruption of reconsolidation could occur in as few as one or two sessions - 
should also promote patient retention in the treatment programme, as these sessions could 
be conducted while the individual was still showing high motivation to discontinue drug use. 
It could be incorporated into standard cue exposure therapy or cognitive behavioural 
therapy in a straightforward manner. Reconsolidation-based therapies might also help to 
prevent the continued stigmatisation of addicts, as there would be fewer outward signs that 
the individual was undergoing therapy to prevent relapse, such as daily medication or 
frequent visits to the clinic. 
 Furthermore, because reconsolidation-based treatments target the CS-drug 
association directly, it is possible that the therapy would show less context-dependence than 
standard extinction therapies, although this has yet to be fully verified experimentally and 
compared to ‘facilitated extinction’ therapies. It is also necessary to establish the nature of 
the amnesia obtained with reconsolidation-based treatments, since an amnesia persisting 
for many months or years would be more clinically useful than an amnesia that lasted for 
only a few weeks. The specificity of the amnesia to the reactivated memory requires further 
investigation, though the sole study investigating this issue suggests that only directly 
reactivated memories undergo reconsolidation (Debiec et al., 2006). The parameters of 
memory reactivation that are optimal to establish a long-lasting amnesia (Lee and Everitt, 
2008) clearly warrant further study, as does the switch between reconsolidation and 
extinction; this will be very important for ensuring that the intended memory is modulated. 
Determining whether instrumental memories reconsolidate will also be extremely important 
for addiction therapy. 
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6. CONCLUSIONS 
Drug addiction is a complex disorder of the nervous system, with potentially a number of 
subtypes (Redish et al., 2008), depending upon the specific vulnerabilities of the individual 
and the drug of abuse. However, a most problematic aspect of treating addiction is the long-
term propensity of the addict to relapse (Gawin and Kleber, 1992), and this is known to be 
profoundly influenced by the presentation of drug-associated, environmental conditioned 
stimuli (Bonson et al., 2002; Boujabit et al., 2003; Childress et al., 1999; Crombag and 
Shaham, 2002; Garavan et al., 2000; Grant et al., 1996; See, 2002; Volkow et al., 1991). This 
suggests that relapse to drug-seeking behaviour is influenced by learned associations, and in 
this sense one way in which it can be conceptualised is as a disorder of aberrantly strong 
learning that leads to maladaptive behaviours (Everitt et al., 2001; Everitt and Robbins, 
2005).  
 An understanding of the psychological and neurobiological mechanisms underlying 
addictive behaviour will inform the development of treatments that target these learned 
associations. One promising form of treatment is that based upon the disruption of memory 
reconsolidation, the process by which memories become labile and susceptible to disruption 
following retrieval. Preclinical studies have suggested that even a single session of treatment 
can lead to the long-term reduction in drug-motivated behaviour, although to date there 
have been no corroborative human studies. Ultimately, addiction can be conceptualised as a 
disorder of learning and memory, and an understanding of the molecular and cellular basis 
of learning within the underlying limbic corticostriatal circuitry should ultimately lead to the 
development of new therapies for the disorder.  
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FIGURE CAPTIONS 
Figure 1. The limbic corticostriatal circuitry implicated in drug addiction. Blue arrows, 
glutamatergic projections; red arrows, dopaminergic projections; pink arrows, GABAergic 
projections; Acb, nucleus accumbens; BLA, basolateral amygdala; CeN, central nucleus of the 
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amygdala; VTA, ventral tegmental area; SNc, substantia nigra pars compacta. GP, globus 
pallidus (D, dorsal; V, ventral). Reproduced, with permission, from Koob, Everitt & Robbins 
(2008). 
 
Figure 2. Zif268 levels increase in the posterior dorsolateral striatum following retrieval of 
a stimulus-response, ‘habit’ memory. (A) Maze procedure adapted from Packard & 
McGaugh (1996). Rats were trained to retrieve a sucrose pellet reward from a particular 
location over an extended period of time (14 sessions). On the probe test day, the maze was 
rotated 180
o
 and entry into one arm was allowed. The arm that was entered was used to 
classify rats as using an A-O or S-R association to complete the task. (B) Levels of Zif268 
expression were analysed using western blotting in the anterior dorsomedial striatum 
(aDMS), the anterior dorsolateral striatum (aDLS), the posterior dorsomedial striatum 
(pDMS) and the posterior dorsolateral striatum (pDLS). Levels of Zif268 expression in the 
pDLS were markedly higher in animals that retrieved the S-R memory (black bars; n = 4) in 
the probe test 2hrs before killing, as compared to animals that were killed 6hrs after the 
probe test (n = 5), and those animals that retrieved the action-outcome (place) memory 
during the probe test (white bars, n = 1 in the 2hr group, n = 4 in the 6hr group; Group: F(3, 
9) = 7.60, p < 0.05). There were no differences in the level of Zif268 expression in the pDMS 
(Group: F(3, 10) = 1.36, p = 0.33), in the aDLS (Group: F < 1) or in the aDMS (Group: F(3, 10) = 
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TABLES 
DSM-IVR ICD10 
Loss of control 
 Substance is often taken in larger amounts 
or over a longer period than intended 
 Persistent desire or unsuccessful efforts to 
cut down or control substance use 
 
Loss of control 
 Difficulties in controlling substance-taking 
behaviour in terms of its onset, termination 
or levels of use 
 A strong desire or sense of compulsion to 
take the substance 
Persistence despite negative consequences 
 Continued substance use despite knowledge 
of having a persistent or recurrent 
psychological or physical problem that is 
caused or exacerbated by use of the 
substance   
 
Persistence despite negative consequences 
 Persisting with substance use despite clear 
evidence of overtly harmful consequences, 
depressive mood states consequent to heavy 
use, or drug related impairment of cognitive 
functioning 
High motivation to take drug 
 A great deal of time is spent in activities 
necessary to obtain the substance, use the 
substance, or recover from its effects 
 Important social, occupational or 
recreational activities given up or reduced 
because of substance abuse 
 
High motivation to take drug 
 Progressive neglect of alternative pleasures 
or interests because of psychoactive 
substance use, increased amount of time 
necessary to obtain or take substance or to 
recover from its effects 
Physiological adaptations 
 Tolerance, as defined by either a need for 
increasing amounts of the substance in order 
to achieve intoxication or desired effect, or a 
markedly diminished effect with continued 
use of the same amount 
 Withdrawal, as manifested by either a 
characteristic withdrawal syndrome for the 
substance, or the same (or closely related) 
substance is taken to relieve or avoid 
withdrawal symptoms 
Physiological adaptations 
 Evidence of tolerance, such that increased 
doses of the psychoactive substance are 
required in order to achieve effects originally 
produced by lower doses 
 A physiological withdrawal state when 
substance use has ceased or been reduced, 
as evidenced by the characteristic 
withdrawal syndrome for the substance, or 
use of the same (or a closely related) 
substance with the intention of relieving or 
avoiding withdrawal symptoms 
Table 1. Definition of ‘substance dependence’ according to DSM-IVR and ICD10. 
 
 




















































The behavioural procedure in which pavlovian conditioned 
approach is induced to a stimulus. See PAVLOVIAN 
CONDITIONED APPROACH. 
 
The process by which a pavlovian CONDITIONED STIMULUS can 
enhance an instrumental response through its appetitive 
motivational properties. This can be reinforcer-specific (i.e. 
a pavlovian CS that predicts the delivery of a particular 
reinforcer can enhance instrumental responding for that 
reinforcer, which has been learned separately) or general 
(i.e. the CS enhances instrumental responding through its 
motivationally activating effects on behaviour). 
 
The process by which a pavlovian CS acquires secondary, or 
conditioned, reinforcing properties that allow it to support 
instrumental responding over delays to primary 
reinforcement, and the acquisition of new instrumental 
responses. 
 
In PAVLOVIAN CONDITIONING, a response that is elicited by 
presentation of the CONDITIONED STIMULUS. This can be the 
same, or different, from the UNCONDITIONED RESPONSE. 
 
In PAVLOVIAN CONDITIONING, a previously motivationally 
neutral stimulus that is associated with an UNCONDITIONED 
STIMULUS or a REINFORCER.  
 
The capacity of an aversive pavlovian CONDITIONED STIMULUS 
to suppress ongoing instrumental responding. 
 
Particularly for drugs of abuse that produce physiological 
tolerance and withdrawal, the phenomenon by which 
contexts and discrete pavlovian CONDITIONED STIMULI become 
associated with the drug withdrawal state, and so elicit 
withdrawal symptoms when they are presented. 
 
In INSTRUMENTAL CONDITIONING, the association by which an 
action that produces a particular outcome (or goal state) is 
represented. Responses are elicited depending upon the 
representation of the outcome, so that if the outcome is 
devalued then the action will not be elicited. 
 
In INSTRUMENTAL CONDITIONING, the association by which a 
pavlovian CONDITIONED STIMULUS elicits a response, which is 
independent of the representation of the outcome. If 
responding is habitual then it will be maintained, even if the 
outcome of the action / response has been devalued. 
Habitual responding is typically seen following overtraining, 
or training in which the contingency between the response 
and the outcome is degraded (e.g. variable interval 
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A type of learning in which the outcome is dependent upon 
the behaviour of the individual. Learning can occur through 
POSITIVE REINFORCEMENT, NEGATIVE REINFORCEMENT or 
PUNISHMENT.  
 
A type of INSTRUMENTAL CONDITIONING procedure in which a 
particular behaviour is increased in frequency due to the 
avoidance of an aversive outcome. 
 
The process by which a pavlovian CONDITIONED STIMULUS 
acquires reinforcing properties that promote approach 
towards that CONDITIONED STIMULUS, and often responses that 
are appropriate to the primary reinforcer (e.g. rats gnawing 
a stimulus that has been paired with food).  
 
A type of learning in which a previously motivationally 
neutral CONDITIONED STIMULUS is paired in space and time with 
a motivationally relevant UNCONDITIONED STIMULUS. The 
behaviour of the individual does not affect the contingency 
between the presentation of the two stimuli. 
 
The behavioural procedure with which CONDITIONED 
MOTIVATION can be assessed. Animals are trained separately 
on an INSTRUMENTAL association and a PAVLOVIAN association 
for the same REINFORCER. At test, the animals are allowed to 
make the instrumental response in the presence of the 
pavlovian stimulus, which is a direct test of conditioned 
motivation (without the pavlovian stimulus acting to 
induce retrieval of the instrumental action representation). 
See CONDITIONED MOTIVATION. 
 
A type of INSTRUMENTAL CONDITIONING procedure in which a 
particular behaviour is increased in frequency due to an 
appetitive outcome. 
 
A type of INSTRUMENTAL CONDITIONING procedure in which a 
particular behaviour is decreased in frequency due to an 
aversive outcome. 
 
A stimulus that alters the probability of an action or 
response being elicited subsequently. This concept does not 
assume that the reinforcer produces any hedonic response 
in the individual. 
 
A stimulus that induces hedonic pleasure. 
 
In PAVLOVIAN CONDITIONING, a response that is elicited by 
presentation of an UNCONDITIONED STIMULUS. 
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Unconditioned stimulus (US) In PAVLOVIAN CONDITIONING, a stimulus that is motivationally 
relevant to the individual (e.g. food, sex). 
Table 2. Definitions of specialised psychological terms. Each is appears in small capitals in 
the text at its first appearance.  
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